Insider Profile
Anderson, William Alexander
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Apr 01, 2026
Most Recent Trade
36
Credibility
Score
78%
Hit Rate
+18.1%
Avg 90d Return
+10.3%
Median 90d Return
9
Evaluated Trades
+74.0%
Best Trade
-19.4%
Worst Trade
Hit rate and returns are based on 9 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
—
Hit Rate · 90d
-11.1%
Median Alpha · 90d
2
Closed Buys Evaluated
0%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 2 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Apr 01, 2026 $DCBO
Docebo
— Comp. Grant Buy 1,573 $24.06 $38K 43
Jan 02, 2026 $DCBO
Docebo
— Comp. Grant Buy 1,243 $30.43 $38K 43
Oct 01, 2025 $DCBO
Docebo
— Comp. Grant Buy 966 $39.16 $38K 43
Jul 02, 2025 $DCBO
Docebo
— Comp. Grant Buy 3,941 $38.05 $150K 43
Jul 01, 2024 $DCBO
Docebo
— Comp. Grant Buy 3,767 $51.95 $196K 43
Jul 01, 2023 $DCBO
Docebo
— Comp. Grant Buy 3,601 $50.54 $182K 43
Jul 04, 2022 $DCBO
Docebo
— Comp. Grant Buy 3,690 $38.97 $144K 43
May 17, 2022 $DCBO
Docebo
— Open Market Buy 4,750 $40.80 $194K 43
Jun 18, 2021 $DCBO
Docebo
— Comp. Grant Buy 1,718 $66.91 $115K 43
Mar 25, 2021 $DCBO
Docebo
— Open Market Buy 5,500 $48.83 $269K 43
Jul 22, 2020 $DCBO
Docebo
— Comp. Grant Buy 2,058 $38.87 $80K 43
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.